TIAA CREF Investment Management’s Heron Therapeutics HRTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $2.81M | Sell |
114,804
-6,723
| -6% | -$164K | ﹤0.01% | 1808 |
|
2018
Q4 | $3.15M | Sell |
121,527
-2,799
| -2% | -$72.6K | ﹤0.01% | 1667 |
|
2018
Q3 | $3.94M | Sell |
124,326
-5,044
| -4% | -$160K | ﹤0.01% | 1736 |
|
2018
Q2 | $5.03M | Buy |
129,370
+5,071
| +4% | +$197K | ﹤0.01% | 1591 |
|
2018
Q1 | $3.43M | Buy |
124,299
+11,765
| +10% | +$325K | ﹤0.01% | 1799 |
|
2017
Q4 | $2.04M | Sell |
112,534
-10,291
| -8% | -$186K | ﹤0.01% | 2118 |
|
2017
Q3 | $1.98M | Buy |
122,825
+1,025
| +0.8% | +$16.6K | ﹤0.01% | 2172 |
|
2017
Q2 | $1.69M | Buy |
121,800
+18,105
| +17% | +$251K | ﹤0.01% | 2279 |
|
2017
Q1 | $1.56M | Buy |
103,695
+12,392
| +14% | +$186K | ﹤0.01% | 2284 |
|
2016
Q4 | $1.2M | Sell |
91,303
-4,469
| -5% | -$58.5K | ﹤0.01% | 2438 |
|
2016
Q3 | $1.65K | Sell |
95,772
-453
| -0.5% | -$8 | ﹤0.01% | 2275 |
|
2016
Q2 | $1.74M | Buy |
96,225
+7,235
| +8% | +$131K | ﹤0.01% | 2212 |
|
2016
Q1 | $1.69M | Sell |
88,990
-11,165
| -11% | -$212K | ﹤0.01% | 2175 |
|
2015
Q4 | $2.67M | Sell |
100,155
-12,559
| -11% | -$335K | ﹤0.01% | 1987 |
|
2015
Q3 | $2.75M | Buy |
112,714
+12,595
| +13% | +$307K | ﹤0.01% | 1951 |
|
2015
Q2 | $3.12M | Buy |
100,119
+23,738
| +31% | +$740K | ﹤0.01% | 2013 |
|
2015
Q1 | $1.11M | Hold |
76,381
| – | – | ﹤0.01% | 2563 |
|
2014
Q4 | $768K | Buy |
76,381
+3,211
| +4% | +$32.3K | ﹤0.01% | 2804 |
|
2014
Q3 | $610K | Buy |
73,170
+679
| +0.9% | +$5.66K | ﹤0.01% | 2888 |
|
2014
Q2 | $893K | Buy |
+72,491
| New | +$893K | ﹤0.01% | 2780 |
|